PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSN27500003Clinical evaluation of NOVEL products for — California Family Health Council Inc

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jul 31, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

National Institutes Of Health Nichd

Awarding office

California Family Health Council Inc

Recipient

Jul 31, 2025

PoP end

$-837,709.42

Obligated

$26.2M

Potential

541712

NAICS

AN11

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs California Family Health Council Inc — $90

Contract facts

Federal

Contract numberHHSN27500003

Also listed asHHSN275201300022I-HHSN27500003

AgencyNational Institutes Of Health Nichd

Awarding officeNational Institutes Of Health Nichd

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentCalifornia Family Health Council Inc

CAGE335K4

UEIKNVJQY9UH316

NAICS541712

No full NAICS 541712 intel page yet. Browse NAICS intelligence

PSCAN11

Parent IDIQ / IDVHHSN275201300022I

Place of performanceLOS ANGELES CA

Pricing typeCost No Fee

Extent competedFull And Open Competition

Related solicitationNIHNICHDIDD20153

PoP startFeb 6, 2014

PoP end (current)Jul 31, 2025

Obligated$-837,709.42

Current value$26.2M

Potential value$26.2M

CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY is a federal award for National Institutes Of Health Nichd held by California Family Health Council Inc. Estimated value $26.2M ($-837,709.42 obligated). Current period of performance ends Jul 31, 2025. Last award drew 1 bidder. Place of performance: LOS ANGELES CA. Related solicitation NIHNICHDIDD20153.

CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY

Recompete timing

Public

● Past PoP end (406 days ago)

Current PoP ended Jul 31, 2025 (406 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HHSN27500003?

HHSN27500003 (Clinical evaluation of NOVEL products for) is a National Institutes Of Health Nichd award with a potential value of $26.2M, currently held by California Family Health Council Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HHSN27500003?

National Institutes Of Health Nichd awarded HHSN27500003 to California Family Health Council Inc (potential $26.2M).

Who is the incumbent on HHSN27500003?

California Family Health Council Inc is the incumbent. The current period of performance ends Jul 31, 2025.

When does California Family Health Council Inc’s HHSN27500003 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 31, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on HHSN27500003 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 27, 2026 · refreshed monthly